Dietary Salt Restriction in Heart Failure: Where Is the Evidence?

详细信息    查看全文

• 作者：James J. DiNicolantonio^a ; ^{jjdinicol@gmail.com" class="auth_mail" title="E-mail the corresponding author} ; Subhankar Chatterjee^b ; James H. O&rsquo ; Keefe^a
• 关键词：ACM ; all-cause mortality ; AVP ; arginine vasopressin ; BP ; blood pressure ; CO ; cardiac output ; CV ; cardiovascular ; CVD ; cardiovascular disease ; HF ; heart failure ; HR ; hazard ratio ; HTN ; hypertension ; MAP ; mean arterial pressure ; NYHA ; New York Heart Association ; RAAS ; renin angiotensin aldosterone system ; SNS ; sympathetic nervous system
• 刊名：Progress in Cardiovascular Diseases
• 出版年：2016
• 出版时间：January-February 2016
• 年：2016
• 卷：58
• 期：4
• 页码：401-406
• 全文大小：309 K

文摘

Several dietary guidelines, health organizations and government policies recommend population-wide sodium restriction to prevent hypertension and related comorbidities like heart failure (HF). The current European Society of Cardiology and American College of Cardiology/American Heart Association Heart Failure guidelines recommend restricting sodium in HF patients. However, these recommendations are based on expert opinion (level C), leading to wide variability in application and lack of consensus among providers pertaining to dietary salt restriction. To evaluate the strength of current evidences to recommend dietary salt restriction among HF patients, we performed a comprehensive literature review and explored the safety and efficacy of such recommendations.